Neo Medical is a Swiss-based technology and innovation company, developing and commercialising holistic surgical solutions for
thoracolumbar fusion

At a glance
Wellness & Welfare
Reference market: Thoracolumbar fusion/ spine surgery
FTEs: ~60
Calendar
Acquisition year: 2024
Investments
Investment type: Growth Capital
Location
Head office: Switzerland
Neo Medical

Investment rationale

  • Differentiated and innovative asset, with a clear and proven value proposition for key stakeholders across all fusion indications, and the potential to disrupt the large addressable spine fusion market
  • The mega-trend of surgical decentralisation into Ambulatory Surgery Centers represents a major structural shift. Neo is uniquely positioned to lead this transformation and serve as the platform of choice
  • Proven growth and success in core EU markets, with a plan to accelerate rapidly through US market development


Positive impact to society

Improving patient outcomes in spinal surgery while reducing the environmental footprint of surgical procedures through innovative disposable instrument systems